OBJECTIVE: The hemodynamic benefit of novel arteriovenous graft (AVG) designs is typically assessed using computational models that assume highly idealized graft configurations and/or simplified boundary conditions representing the peripheral vasculature. The objective of this study is to evaluate whether idealized AVG models are suitable for hemodynamic evaluation of new graft designs, or whether more realistic models are required.METHODS: An idealized and a realistic, clinical imaging based, parametrized AVG geometry were created. Furthermore, two physiological boundary condition models were developed to represent the peripheral vasculature. We assessed how graft geometry (idealized or realistic) and applied boundary condition models of t...
BackgroundExperimental modeling of arteriovenous hemodialysis fistula (AVF) hemodynamics is challeng...
Although arterio-venous grafts (AVGs) are the second best option as permanent vascular access for he...
Compliance mismatch between an arteriovenous dialysis graft (AVG) and the connected vein is believed...
OBJECTIVE: The hemodynamic benefit of novel arteriovenous graft (AVG) designs is typically assessed ...
ObjectiveThe hemodynamic benefit of novel arteriovenous graft (AVG) designs is typically assessed us...
Objective: Arteriovenous grafts (AVGs) typically lose patency within two years of creation due to ve...
Disturbed flow and the resulting non-physiological wall shear stress (WSS) at the graft-vein anastom...
Although arterio-venous grafts (AVGs) represent the second choice as permanent vascular access forhe...
peer-reviewedRenal failure is a condition where the kidneys cannot provide sufficient filtration of ...
Arteriovenous graft (AVG) is artificially made with graft for hemodialysis in the patients with rena...
Hemodialysis is a common treatment for ESRD patients to manage their chronic renal failure while awa...
Hemodialysis is a common treatment for end-stage renal-disease patients to manage their renal failur...
Hemodialysis is a common treatment for ESRD patients to manage their chronic renal failure while awa...
Patients with end-stage renal disease are usually treated by hemodialysis while waiting for a kidney...
BackgroundExperimental modeling of arteriovenous hemodialysis fistula (AVF) hemodynamics is challeng...
Although arterio-venous grafts (AVGs) are the second best option as permanent vascular access for he...
Compliance mismatch between an arteriovenous dialysis graft (AVG) and the connected vein is believed...
OBJECTIVE: The hemodynamic benefit of novel arteriovenous graft (AVG) designs is typically assessed ...
ObjectiveThe hemodynamic benefit of novel arteriovenous graft (AVG) designs is typically assessed us...
Objective: Arteriovenous grafts (AVGs) typically lose patency within two years of creation due to ve...
Disturbed flow and the resulting non-physiological wall shear stress (WSS) at the graft-vein anastom...
Although arterio-venous grafts (AVGs) represent the second choice as permanent vascular access forhe...
peer-reviewedRenal failure is a condition where the kidneys cannot provide sufficient filtration of ...
Arteriovenous graft (AVG) is artificially made with graft for hemodialysis in the patients with rena...
Hemodialysis is a common treatment for ESRD patients to manage their chronic renal failure while awa...
Hemodialysis is a common treatment for end-stage renal-disease patients to manage their renal failur...
Hemodialysis is a common treatment for ESRD patients to manage their chronic renal failure while awa...
Patients with end-stage renal disease are usually treated by hemodialysis while waiting for a kidney...
BackgroundExperimental modeling of arteriovenous hemodialysis fistula (AVF) hemodynamics is challeng...
Although arterio-venous grafts (AVGs) are the second best option as permanent vascular access for he...
Compliance mismatch between an arteriovenous dialysis graft (AVG) and the connected vein is believed...